Patent | Date |
---|
Lipid Construct For Delivery Of Insulin To A Mammal App 20220110870 - LAU; JOHN R. ;   et al. | 2022-04-14 |
Lipid-based Nanoparticles And Use Of Same In Optimized Insulin Dosing Regimens App 20210379160 - Geho; W. Blair | 2021-12-09 |
Lipid-based nanoparticles and methods using same Grant 11,077,173 - Geho August 3, 2 | 2021-08-03 |
Lipid-based nanoparticles and methods using same Grant 11,071,715 - Geho July 27, 2 | 2021-07-27 |
Lipid-based Nanoparticles With Enhanced Stability App 20210137838 - Geho; W. Blair | 2021-05-13 |
Lipid-based nanoparticles and use of same in optimized insulin dosing regimens Grant 10,918,700 - Geho February 16, 2 | 2021-02-16 |
Orally Bioavailable Lipid-based Constructs App 20200405638 - Lau; John R. ;   et al. | 2020-12-31 |
Compositions Comprising Lipid-based Nanoparticles For Treating Diabetes Mellitus App 20200375913 - Geho; W. Blair | 2020-12-03 |
Lipid-based Nanoparticles And Methods Using Same App 20200330560 - Geho; W. Blair | 2020-10-22 |
Lipid-based Nanoparticles And Use Of Same In Optimized Insulin Dosing Regimens App 20200323961 - Geho; W. Blair | 2020-10-15 |
Orally bioavailable lipid-based constructs Grant 10,751,418 - Geho , et al. A | 2020-08-25 |
Lipid Construct For Delivery Of Insulin To A Mammal App 20200261363 - LAU; JOHN R. ;   et al. | 2020-08-20 |
Orally bioavailable lipid-based constructs Grant 10,568,835 - Lau , et al. Feb | 2020-02-25 |
Lipid-based Nanoparticles And Methods Using Same App 20200022922 - Geho; W. Blair | 2020-01-23 |
Lipid construct for delivery of insulin to a mammal Grant 10,463,616 - Lau , et al. No | 2019-11-05 |
Lipid Construct For Delivery Of Insulin To A Mammal App 20190054021 - LAU; JOHN R. ;   et al. | 2019-02-21 |
Lipid construct for delivery of insulin to a mammal Grant 10,004,686 - Lau , et al. June 26, 2 | 2018-06-26 |
Orally bioavailable lipid-based constructs Grant 9,943,602 - Geho , et al. April 17, 2 | 2018-04-17 |
Orally bioavailable lipid-based constructs Grant 9,145,453 - Geho , et al. September 29, 2 | 2015-09-29 |
Lipid construct for delivery of insulin to a mammal Grant 9,034,372 - Lau , et al. May 19, 2 | 2015-05-19 |
Orally Bioavailable Lipid-based Constructs App 20150125518 - LAU; JOHN R. ;   et al. | 2015-05-07 |
Orally bioavailable lipid-based constructs Grant 8,962,015 - Lau , et al. February 24, 2 | 2015-02-24 |
Lipid Construct For Delivery Of Insulin To A Mammal App 20150031608 - LAU; JOHN R. ;   et al. | 2015-01-29 |
Orally bioavailable lipid-based constructs Grant 8,846,053 - Geho , et al. September 30, 2 | 2014-09-30 |
Orally Bioavailable Lipid-based Constructs App 20140243430 - GEHO; W. BLAIR ;   et al. | 2014-08-28 |
Lipid Construct for Delivery of Insulin to a Mammal App 20130267462 - Lau; John R. ;   et al. | 2013-10-10 |
Orally Bioavailable Lipid-Based Constructs App 20130183270 - Geho; W. Blair ;   et al. | 2013-07-18 |
Targeted liposomal drug delivery system Grant 8,303,983 - Lau , et al. November 6, 2 | 2012-11-06 |
Method of increasing the bioavailability of recombinant human insulin isophane in a patient Grant 8,257,735 - Lau , et al. September 4, 2 | 2012-09-04 |
Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments App 20120035105 - Geho; W. Blair ;   et al. | 2012-02-09 |
Lipid Construct for Delivery of Insulin to a Mammal App 20110135725 - Lau; John R. ;   et al. | 2011-06-09 |
Hepatocyte Delivery Vehicle for Delivery of a Combination of Recombinant Human Regular Insulin and Recombinant Human Insulin Isophane to a Mammal App 20110135727 - Lau; John R. ;   et al. | 2011-06-09 |
Hepatocyte-targeting vehicle for delivery of glargine insulin to a mammal Grant 7,871,641 - Lau , et al. January 18, 2 | 2011-01-18 |
Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal Grant 7,858,116 - Lau , et al. December 28, 2 | 2010-12-28 |
Orally Bioavailable Lipid-Based Constructs App 20100310599 - GEHO; W. Blair ;   et al. | 2010-12-09 |
Orally Bioavailable Lipid-Based Constructs App 20100247625 - Geho; W. Blair ;   et al. | 2010-09-30 |
Targeted Liposomal Drug Delivery System App 20100209492 - Lau; John R. ;   et al. | 2010-08-19 |
Supra Molecular Construct For Delivery Of Interferon To A Mammal App 20100129428 - Lau; John R. ;   et al. | 2010-05-27 |
Orally Bioavailable Lipid-Based Constructs App 20100080773 - Geho; W. Blair ;   et al. | 2010-04-01 |
Orally bioavailable lipid-based constructs App 20090087479 - Lau; John R. ;   et al. | 2009-04-02 |
Supra molecular construct for delivery of interferon to a mammal App 20070218117 - Lau; John R. ;   et al. | 2007-09-20 |
Targeted liposomal drug delivery system App 20070104777 - Lau; John R. ;   et al. | 2007-05-10 |
Targeted liposomal drug delivery system Grant 7,169,410 - Lau , et al. January 30, 2 | 2007-01-30 |
Hepatocyte delivery vehicle for delivery of glargine insulin to a mammal App 20060222698 - Lau; John R. ;   et al. | 2006-10-05 |
Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal App 20060222697 - Lau; John R. ;   et al. | 2006-10-05 |
Dual therapy method of treating and controlling diabetes mellitus App 20020177546 - Geho, W. Blair ;   et al. | 2002-11-28 |
Method of preventing and treating the complications of insulin dependent diabetes mellitus App 20020147134 - Geho, W. Blair ;   et al. | 2002-10-10 |
Prevention or treatment of complications related to non-insulin dependent diabetes mellitus or type 2 diabetes mellitus App 20020137787 - Geho, W. Blair ;   et al. | 2002-09-26 |
Masking of liposomes from RES recognition Grant 6,177,099 - Lau , et al. January 23, 2 | 2001-01-23 |
Targeted liposomal constructs for diagnostic and therapeutic uses Grant 6,063,400 - Geho , et al. May 16, 2 | 2000-05-16 |
Hair penetrant and carrier Grant 5,436,010 - Lau , et al. July 25, 1 | 1995-07-25 |
Diabetic control by combined insulin forms Grant 4,863,896 - Geho , et al. September 5, 1 | 1989-09-05 |
Gelcores Grant 4,740,375 - Geho , et al. April 26, 1 | 1988-04-26 |
Antitoxin vaginal products and catamenials Grant 4,722,937 - Jacob , et al. * February 2, 1 | 1988-02-02 |
Treatment for hyperactivity Grant 4,704,394 - Geho November 3, 1 | 1987-11-03 |
Hepatocyte Directed Vesicle delivery system Grant 4,603,044 - Geho , et al. July 29, 1 | 1986-07-29 |
Treatment for hypoglycemia Grant 4,602,043 - Geho July 22, 1 | 1986-07-22 |
Masking of liposomes from RES recognition Grant 4,501,728 - Geho , et al. February 26, 1 | 1985-02-26 |